Clearpoint Neuro Inc. · NASDAQ:CLPT
Clearpoint Neuro — MRI Interventions — Investor Presentation (April 2018)
25 slides from Clearpoint Neuro's investor presentation, Apr 10, 2018
Slide 1: Investor Presentation
Investor Presentation Joe Burnett, President & CEO April 2018 © 2018 MRI INTERVENTIONS, INC. | 1
Slide 2: Forward Looking Statements
Forward Looking Statements Statements herein concerning MRI Interventions, Inc. (the “Company”) plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance
Slide 3: Leading the Movement to Minimally Invasive Neurosurgery
Leading the Movement to Minimally Invasive Neurosurgery © 2018 MRI INTERVENTIONS, INC. | 3
Slide 4: Traditional Stereotactic Neurosurgery is Limited
Traditional Stereotactic Neurosurgery is Limited 3 Primary Challenges: 1. The Scull is not ‘See Through’ 2. X-Ray does not show structures of the brain, and Large, Metallic Frames are not compatible inside an MRI Magnet 3. Precision is lost for each ‘estimate’ made to keep the procedure in the OR Ad
Slide 5: The Solution: ClearPoint Neuro Navigation System Platform
The Solution: ClearPoint® Neuro Navigation System Platform The only Neuro-Navigation System with ‘Sub-millimeter’ Accuracy ClearPoint Procedure Overview: ClearPoint Video Entry and Trajectory ClearPoint Video Alignment and Insertion © 2018 MRI INTERVENTIONS, INC. | 5
Slide 6: Our Unique Value: We Decide, Guide & Confirm
Our Unique Value: We DECIDE, GUIDE & CONFIRM the most challenging neurosurgery therapies Decide 1 Advanced Planning Software and Fusion Algorithms enable ‘Fly Through’ entry point and trajectory planning the day of the procedure using live MRI Images Guide 2 Uniquely enable changes to trajectory liv
Slide 7: MRIC: The Premier Company for Precision MRI-Guided Therapy
MRIC: The Premier Company for Precision MRI-Guided Therapy MRI Interventions: Leader in Precision MRI-Guided Therapy Unique Platform that allows delivery of therapies to the brain with pinpoint accuracy under live MRI Guidance Entire procedure can take place in the MRI suite, reducing the risk of ho
Slide 8: Precision MRI-Guided Platform: ClearPoint Neuro Navigation System
Precision MRI-Guided Platform: ClearPoint Neuro Navigation System ClearPoint Components: Capital Sale Reusable Hardware Components Integrated Software Recurring Revenue Single-Use, Disposable Components $100K - $175K ASP ~$7,500 ASP Procedure Emory University Hospital Univ. of California San Francis
Slide 9: Broad and Growing User Base of Leading Neurosurgeons
Broad and Growing User Base of Leading Neurosurgeons ClearPoint Is Installed in 52 Top US Hospitals and Growing UC San Francisco San Francisco VA Stanford Univ UCSF Benioff Childrens USC UC San Diego Univ of Colo Univ of Utah Univ of Arizona Cook Children’s MD Anderson Methodist Hosp Texas Children’
Slide 10: Our MRI-Guided Therapy Platform is Currently Being Used to
Our MRI-Guided Therapy Platform is Currently Being Used to: Implant Neuro Stimulation Leads from: Medtronic St. Jude Medical Boston Scientific NeuroPace Place Laser Ablation Probes from: Medtronic-Visualase Monteris Medical Deliver Biologics and Drugs from: Voyager Medicenna Oxford Biomedica Interna
Slide 11: ClearPoint Neurosurgical Procedure Growth
ClearPoint Neurosurgical Procedure Growth © 2018 MRI INTERVENTIONS, INC. | 11
Slide 12: Consistent Revenue Growth Since 2013
Consistent Revenue Growth Since 2013 > 80% of 2017 revenue from single-use disposable kits and cannulas © 2018 MRI INTERVENTIONS, INC. | 12
Slide 13: MRIC: Part Growth Strategy
MRIC: 4 Part Growth Strategy Target Indications of > 150,000 procedures per year represents Potential Addressable Market for MRIC of $1B+ Note: Market sizes for brain tumor, ICH are Pancreatic cancer are incidence numbers because of the nature of those diseases. Prevalence numbers are based on eithe
Slide 14: Grow Our Core Functional Neurosurgery Business
Part 1 Grow Our Core Functional Neurosurgery Business Focus Complex Procedures Where Precision is Paramount Electrode Placement for Deep Brain Stimulation Laser Catheter Placement for Ablation Procedures Key Strategies Add 8-10 new centers from existing funnel via capital sales and evaluation agreem
Slide 15: Grow Our Core Functional Neurosurgery Business: ClearPoint 2.0
Part 1 Grow Our Core Functional Neurosurgery Business Focus Complex Procedures Where Precision is Paramount ClearPoint 2.0 Image Fusion Feature (Not Commercially Available) © 2018 MRI INTERVENTIONS, INC. | 15
Slide 16: Become the Premier Partner for Biologics and Drug Delivery
Part 2 Become the Premier Partner for Biologics and Drug Delivery Focused Resources for Branding, Device Development and Distribution Precise, Quantifiable Drug Delivery ClearPoint 2.0 Software (not commercially available) Key Strategies & Tactics for 2018: Assign a ‘Sales Portfolio Manager’ to proa
Slide 17: Become the Premier Partner for Biologics and Drug Delivery
Part 2 Become the Premier Partner for Biologics and Drug Delivery Focused Resources for Branding, Device Development and Distribution © 2018 MRI INTERVENTIONS, INC. | 17
Slide 18: Become the Premier Partner for Biologics and Drug Delivery
Part 2 Become the Premier Partner for Biologics and Drug Delivery Focused Resources for Branding, Device Development and Distribution © 2018 MRI INTERVENTIONS, INC. | 18
Slide 19: Expand into Direct Therapy Markets
Part 3 Expand into Direct Therapy Markets Achieve first-in-human case for our Neuro-Aspiration System Integrated Therapy Products benefit the patient and hospital by simplifying workflow and making procedures more efficient and cost effective Adding therapy helps MRIC generate additional revenue per
Slide 20: Expand into Direct Therapy Markets: ClearAway for ICH
Part 3 Expand into Direct Therapy Markets Achieve first-in-human case for our Neuro-Aspiration System Initial Stroke Product (ClearAway ) Targets Intracerebral Hemorrhage (ICH) Collaboration with Mayo Clinic Only major stroke subtype w/o clearly effective therapy major unmet medical need Affects 80,
Slide 21: Achieve Business Model Scale, Go Global
Part 4 Achieve Business Model Scale, Go Global Execute initiatives along a path-to-profitability Relocating Clinical Specialists closer to case ‘clusters’ to reduce travel Hiring new specialists to locations where new placements are planned Prioritize shorter procedure times so two cases are perform
Slide 22: Achieve Business Model Scale, Go Global: Manufacturing
Part 4 Achieve Business Model Scale, Go Global Execute initiatives along a path-to-profitability Manufacturing Facility in Irvine, CA Current facility capable of producing 5x more product without expansion Target gross margin expansion above 70% in next five years SmartFlow® Drug Delivery Cannula Gl
Slide 23: Cash Flow From Operations
Cash Flow From Operations*: 2015 2017 *Excludes interest payments, non-cash compensation and financing costs © 2018 MRI INTERVENTIONS, INC. | 23
Slide 24: Experienced Medical Device Management Team
Experienced Medical Device Management Team Management Team Joseph Burnett CEO Peter Piferi COO Wendelin Maners VP Marketing Hal Hurwitz CFO Board of Directors Joseph Kimble Jenkins, John Fletcher Pascal Girin Timothy Maria Sainz Jack Spencer Burnett Chairman Richards Managing Partner, Founder © 2018
Slide 25: MRIC: Executive Summary
MRIC: Executive Summary Unique, Platform technology enabling Precision MRI-Guided Therapies to restore quality of life for some of the most debilitating disorders Large, Growing installed base in 52 of 250+ leading Neurology centers in U.S. Procedure volume has grown 43%+ CAGR from 2013-2017 80%+ of
MRI Interventions — Investor Presentation (April 2018) on 6ix